Paper23908736
AIDS and drug rationing.
Sharif PS and 1 other. J Med Ethics Hist Med, 2010. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. AIDS and drug rationing. Papers, record 23908736. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23908736
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 16652038 | Potential impact of antiretroviral therapy on HIV-1 transmission and AIDS mortality in resource-limited settings. | J Acquir Immune Defic Syndr | 2006 | https://conductscience.org/library/papers/16652038 | PubMed |
| 2 | 18832873 | Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification. | AIDS | 2008 | https://conductscience.org/library/papers/18832873 | PubMed |
| 3 | 9357338 | Ethical challenges posed by clinical progress in AIDS. | Am J Public Health | 1997 | https://conductscience.org/library/papers/9357338 | PubMed |
| 4 | 17243067 | Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy. | Clin Infect Dis | 2007 | https://conductscience.org/library/papers/17243067 | PubMed |
| 5 | 16563042 | Rational choices for allocating antiretrovirals in Africa: treatment equity, epidemiological efficiency, and feasibility. | PLoS Med | 2006 | https://conductscience.org/library/papers/16563042 | PubMed |
| 6 | 11873003 | HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? | AIDS | 2002 | https://conductscience.org/library/papers/11873003 | PubMed |
| 7 | 15097305 | Can highly active antiretroviral therapy reduce the spread of HIV?: A study in a township of South Africa. | J Acquir Immune Defic Syndr | 2004 | https://conductscience.org/library/papers/15097305 | PubMed |
| 8 | 16159308 | Rationing antiretroviral therapy for HIV/AIDS in Africa: choices and consequences. | PLoS Med | 2005 | https://conductscience.org/library/papers/16159308 | PubMed |
| 9 | 17227932 | Survival of persons with and without HIV infection in Denmark, 1995-2005. | Ann Intern Med | 2007 | https://conductscience.org/library/papers/17227932 | PubMed |
| 10 | 16530575 | Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. | Lancet | 2006 | https://conductscience.org/library/papers/16530575 | PubMed |
| 11 | 16741877 | The survival benefits of AIDS treatment in the United States. | J Infect Dis | 2006 | https://conductscience.org/library/papers/16741877 | PubMed |
| 12 | 16430196 | Efficacy and safety of indinavir/ritonavir 400/100 mg twice daily plus two nucleoside analogues in treatment-naive HIV-1-infected patients with CD4+ T-cell counts <200 cells/mm3: 96-week outcomes. | Antivir Ther | 2005 | https://conductscience.org/library/papers/16430196 | PubMed |
| 13 | 14760894 | Efficacy and safety of ritonavir/indinavir 100/400 mg twice daily in combination with two nucleoside analogues in antiretroviral treatment-naive HIV-infected individuals. | Antivir Ther | 2003 | https://conductscience.org/library/papers/14760894 | PubMed |
| 14 | 16355337 | Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda. | Clin Infect Dis | 2006 | https://conductscience.org/library/papers/16355337 | PubMed |
| 15 | 15883177 | Low-doses of indinavir boosted with ritonavir in HIV-infected Thai patients: pharmacokinetics, efficacy and tolerability. | J Antimicrob Chemother | 2005 | https://conductscience.org/library/papers/15883177 | PubMed |
| 16 | 16860698 | Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial. | Lancet | 2006 | https://conductscience.org/library/papers/16860698 | PubMed |
| 17 | 19020325 | Early antiretroviral therapy and mortality among HIV-infected infants. | N Engl J Med | 2008 | https://conductscience.org/library/papers/19020325 | PubMed |
| 18 | 17457091 | HIV drug resistance surveillance for prioritizing treatment in resource-limited settings. | AIDS | 2007 | https://conductscience.org/library/papers/17457091 | PubMed |
| 19 | 16691068 | Generic fixed-dose combination antiretroviral treatment in resource-poor settings: multicentric observational cohort. | AIDS | 2006 | https://conductscience.org/library/papers/16691068 | PubMed |
| 20 | 11172188 | Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. | N Engl J Med | 2001 | https://conductscience.org/library/papers/11172188 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23908736
GET https://conductscience.org/api/papers/v1/23908736/references?page=2